GetTopicDetailResponse(id=551f655204, topicName=EFDA-101, introduction=EFDA-101, content=null, image=null, comments=1, allHits=644, url=https://h5.medsci.cn/topic?id=6552, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=100369, tagList=[TagDto(tagId=100369, tagName=EFDA-101)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1785043, encodeId=452b1e85043c1, content=<a href='/topic/show?id=551f655204' target=_blank style='color:#2F92EE;'>#EFDA-101#</a>, objectTitle=EHP的大麻雙酚衍生物口服制劑EFDA-101治療系統(tǒng)性硬化癥，獲得美國FDA的快速通道指定, objectType=article, longId=189522, objectId=bca518952213, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bca518952213, replyNumber=0, likeNumber=102, createdTime=2020-06-28, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bca518952213, moduleTitle=EHP的大麻雙酚衍生物口服制劑EFDA-101治療系統(tǒng)性硬化癥，獲得美國FDA的快速通道指定, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=bca518952213)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
